The Bad Guys 2 is not yet available to watch on a streaming service that’s subscription-based, but we do expect to see The Bad Guys 2 streaming on Peacock soon, free to anyone with a Peacock ...

IU's alumni network is full of trailblazers, with names like Suzanne Collins and Mark Cuban often getting most of the ...

Lilly Singh is stepping from YouTube stand-out to host on NBC late-night, replacing Carson Daly. Singh, 30, announced her new show, “A Little Late With Lilly Singh," while a guest on "The ...

Viking Therapeutics reported positive Phase 2 results for VK2735, showing significant weight loss and safety in obesity ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE ...

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off is excessive.

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival Novo Nordisk did on Tuesday, and are anxiously awaiting a full-year ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage study, but that was less than previous trial results for Novo Nordisk's ...

The Vanity Fair Oscar after-party is always a star-studded affair, and this year’s celebration at the Wallis Annenberg Center for the Performing Arts in Beverly Hills was no exception.

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors remain unconvinced.

Lilly's late-stage results for its experimental oral obesity drug raised concerns.